92 related articles for article (PubMed ID: 739695)
1. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
Hara N; Yosida T; Said SI
Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
[No Abstract] [Full Text] [Related]
2. [Effect of ipratropium bromide (Sch 1000) on the action of various bronchoactive agents (author's transl)].
Ishihara Y; Izumi T; Hayashi R; Hsu LH; Sugiyama Y; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Aug; 18(8):501-5. PubMed ID: 6448308
[No Abstract] [Full Text] [Related]
3. Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin-F2 alpha-induced activity of the rabbit myometrium.
Ottesen B; Wagner G; Fahrenkrug J
Prostaglandins; 1980 Mar; 19(3):427-35. PubMed ID: 7384549
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi.
Tam EK; Franconi GM; Nadel JA; Caughey GH
Am J Respir Cell Mol Biol; 1990 May; 2(5):449-52. PubMed ID: 2187492
[TBL] [Abstract][Full Text] [Related]
5. [Experimental investigation on pathogenesis of paraben-induced asthma (author's transl)].
Kitamura S; Ishihara Y; Kosaka K; Suetsugu S; Homma R; Umeda H
Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Apr; 17(4):244-9. PubMed ID: 480729
[No Abstract] [Full Text] [Related]
6. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
Lonovics J; Devitt P; Rayford PL; Thompson JC
Surg Forum; 1979; 30():407-9. PubMed ID: 538649
[No Abstract] [Full Text] [Related]
7. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure.
Ryan J; Cohen S
Gastroenterology; 1977 Oct; 73(4 Pt 1):870-2. PubMed ID: 892388
[TBL] [Abstract][Full Text] [Related]
8. [Effect of acetylcholine, bradykinin, and vasoactive intestinal polypeptide on the canine airways and pulmonary vascular bed (author's transl)].
Sugiyama Y; Hsu LH; Ishihara Y; Kitamura S; Kosaka K
Kokyu To Junkan; 1982 Apr; 30(4):387-91. PubMed ID: 7100681
[No Abstract] [Full Text] [Related]
9. Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle.
Suzuki R; Kobayashi S
Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):250-3. PubMed ID: 6826329
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
Ottesen B
Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
[TBL] [Abstract][Full Text] [Related]
11. [Inhalation of a precursor analogue of vasoactive intestinal polypeptide (Leu17 VIP-Gly-Lys) protects ascaris-induced bronchoconstriction in dog].
Hamada M; Uchida Y; Inoue M; Kameyama M; Nomura A; Ohtsuka M; Itoh O; Tachibana S; Hasegawa S
Arerugi; 1989 Dec; 38(12):1347-53. PubMed ID: 2634376
[TBL] [Abstract][Full Text] [Related]
12. Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.
O'Donnell M; Garippa RJ; Rinaldi N; Selig WM; Simko B; Renzetti L; Tannu SA; Wasserman MA; Welton A; Bolin DR
J Pharmacol Exp Ther; 1994 Sep; 270(3):1282-8. PubMed ID: 7932180
[TBL] [Abstract][Full Text] [Related]
13. [Vasoactive intestinal polypeptide (VIP) (author's transl)].
Kachelhoffer J; Marescaux J; Michel F; Grenier JF
Gastroenterol Clin Biol; 1979 Apr; 3(4):381-95. PubMed ID: 499699
[No Abstract] [Full Text] [Related]
14. [Regulation of gastrointestinal motility by gastrointestinal hormones (author's transl)].
Takeuchi S; Ito S
Horumon To Rinsho; 1979; 27(12):1379-85. PubMed ID: 397014
[No Abstract] [Full Text] [Related]
15. Relaxant action of VIP on cat pulmonary artery: comparison with acetylcholine, isoproterenol, and PGE1.
Hamasaki Y; Mojarad M; Said SI
J Appl Physiol Respir Environ Exerc Physiol; 1983 Jun; 54(6):1607-11. PubMed ID: 6874483
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms of action of vasoactive intestinal polypeptide (VIP) and glucagon on intestinal secretion.
Mailman D
Gastroenterology; 1977 Dec; 73(6):1463-5. PubMed ID: 913990
[No Abstract] [Full Text] [Related]
17. Vasodilatory effects of vasoactive intestinal polypeptide (VIP) on isolated rat arteries.
Suzuki Y; Kobayashi Y; Lederis K
Proc West Pharmacol Soc; 1983; 26():341-4. PubMed ID: 6889362
[No Abstract] [Full Text] [Related]
18. [The effect of VIP on cyclic nucleotides contents of guinea-pig lung and tracheal tissues (author's transl)].
Kitamura S; Ishihara Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Jun; 15(6):205-300. PubMed ID: 198597
[No Abstract] [Full Text] [Related]
19. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
Franconi GM; Graf PD; Lazarus SC; Nadel JA; Caughey GH
J Pharmacol Exp Ther; 1989 Mar; 248(3):947-51. PubMed ID: 2495355
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea pigs.
Kanazawa H; Kawaguchi T; Shoji S; Fujii T; Kudoh S; Hirata K; Kurihara N; Yoshikawa J
Am J Respir Crit Care Med; 1997 Feb; 155(2):747-50. PubMed ID: 9032223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
